Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29328591 | 0.99 | CYP4F2 (0.40) | CYP4F2CYP4A11CYP2C19CYP3A4TSHR | |
| SCHEMBL29168788 | 0.87 | SIRT2 (0.40) | CYP4F2CYP4A11CYP2C19CYP3A4TSHR | |
| SCHEMBL28553004 | 0.85 | SIRT2 (0.43) | CYP4F2CYP4A11CYP2C19CYP3A4 | |
| SCHEMBL31369191 | 0.84 | CYP4F2 (0.36) | CYP4F2CYP4A11CYP2C19CYP3A4TSHR | |
| SCHEMBL2648433 | 0.83 | CYP2C19 (0.36) | CYP4F2CYP4A11CYP2C19CYP3A4TSHR | |
| SCHEMBL1044076 | 0.81 | — | — | |
| SCHEMBL7626939 | 0.81 | CYP2C19 (0.36) | CYP4F2CYP4A11CYP2C19CYP3A4TSHR | |
| SCHEMBL10685038 | 0.81 | CYP2C19 (0.37) | CYP4F2CYP4A11CYP2C19CYP3A4TSHR | |
| SCHEMBL25224337 | 0.81 | TSHR (0.39) | CYP4F2CYP4A11TSHRNPSR1 | |
| SCHEMBL26102395 | 0.81 | TSHR (0.39) | CYP4F2CYP4A11TSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151112-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR | 주식회사 티움바이오 | 2024-07-18 | — | — | WO | disclosed |